Bed Bath & Beyond Finalizes CEO Marcus Lemonis's Compensation Package, Including $15.57M in Equity
BBBY has more than doubled off its 52-week low of $3.54.
Summary
Bed Bath & Beyond, Inc. filed an amendment to disclose the compensation package for its new CEO, Marcus Lemonis, including a $300,000 base salary, a $2.2 million target annual bonus, and initial equity awards valued at approximately $15.57 million.
Key Events · Executive and Board Changes · BBBY
-
CEO Compensation Details
Marcus Lemonis's employment agreement includes a $300,000 base salary and a $2.2 million target annual cash bonus.
-
Significant Initial Equity Grant
Initial equity awards comprise 1.5 million restricted stock units and 600,000 performance shares, valued at approximately $15.57 million based on the current stock price.
-
Future Annual Equity Awards
Starting in calendar year 2027, Mr. Lemonis is eligible for annual equity awards with an aggregate target value of $4.5 million.
-
Stockholder Approval Required
The initial equity awards are contingent on stockholder approval at the company's 2026 annual meeting of stockholders.
Analysis · BBBY · Trade & Services
This 8-K/A provides crucial details on the compensation structure for newly appointed CEO Marcus Lemonis, following his appointment on January 5, 2026. The substantial equity grant, valued at approximately $15.57 million based on the current stock price, represents a significant incentive for Mr. Lemonis to drive the company's strategic initiatives, including the recently announced acquisition of The Brand House Collective. While the compensation package is substantial and involves potential dilution, it is a critical component in securing and motivating executive leadership during a period of significant corporate transformation. Investors should monitor the upcoming 2026 annual meeting for the required stockholder approval of the equity awards.
At the time of this filing, BBBY was trading at $7.42 on NYSE in the Trade & Services sector, with a market capitalization of approximately $510.9M. The 52-week trading range was $3.54 to $12.65. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.